2020 Application

We are pleased to announce that the NINDS Clinical Trials Methodology Course (CTMC) is accepting applications for the 2020 cohort. The overarching goal of the CTMC is to help investigators develop scientifically rigorous, yet practical clinical trial protocols. Our focus is on investigators who have not previously designed their own prospective, interventional clinical trials. 

Informational Webinar (January 7, 2020 at 12pm EST):

 
Course:

There is a combination of distance learning activities and a REQUIRED residential course, along with small group mentorship from experienced clinical trialists and biostatisticians. The residential part of the course will be held July 20 – 23, 2020 in Ann Arbor, MI. Funding for travel (within the US) and accommodations will be provided for participants.

Who Should Apply?

Qualified applicants from clinical disciplines focused on neurological disease or injury, along with biostatisticians working on projects with clinical neuroscience researchers should apply. All preliminary trial ideas are encouraged, but it is REQUIRED that protocols be focused on the clinical neurosciences. Trainees should have content area mentors to assist them with the science and implementation of their project. A small number of projects may qualify for additional work using clinical trial simulation.

Application:

The link to the application is here

NOTE: The application submission portal is where your application materials will be submitted. The portal also includes demographic and professional background questions; a PDF of these can be viewed here

DEADLINE:

The application submission deadline is February 28, 2020 at midnightApplication forms and additional details are available on the course website: http://neurotrials.training. Early applications may be considered for early acceptance.

Have Questions?

Please contact ninds-ctmc-info@umich.edu or William Meurer, MD, MS with any questions.

Thank you.

The NINDS Clinical Trials Methodology Course is supported by the NIH‐NINDS grant R25 NS088248 and is administered by the University of Michigan, the University of Iowa, and Los Angeles BioMed. Additional support is provided by the American Academy of Neurology.